Literature DB >> 15925988

Aberrant TP53 protein accumulation in the neuronal component of ganglioglioma.

Takao Fukushima1, Yoichi Katayama, Takao Watanabe, Atsuo Yoshino, Chiaki Komine, Takakazu Yokoyama.   

Abstract

Gangliogliomas are characterized by their different phenotypic composition of ganglion cells and glial cells. In contrast to the glial cells that are capable of mitotic activity, the ganglion cells are generally considered to lack a neoplastic nature. The authors report here the first unequivocal case of a ganglioglioma harboring aberrant TP53 product that was expressed predominantly in the neuronal component. GeneChip TP53 assay revealed a point mutation resulting in an exchange of amino acid. This case suggests that ganglion cells can participate in the neoplastic process of gangliogliomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925988     DOI: 10.1007/s11060-004-3549-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  13 in total

1.  Ganglioglioma: an ultrastructural and immunohistochemical study.

Authors:  T Hirose; B W Scheithauer; M B Lopes; H A Gerber; H J Altermatt; S R VandenBerg
Journal:  Cancer       Date:  1997-03-01       Impact factor: 6.860

2.  Gangliogliomas: pathological and clinical correlation.

Authors:  J H Johannsson; H L Rekate; U Roessmann
Journal:  J Neurosurg       Date:  1981-01       Impact factor: 5.115

3.  Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis. Case report.

Authors:  Y Hayashi; M Iwato; M Hasegawa; O Tachibana; A von Deimling; J Yamashita
Journal:  J Neurosurg       Date:  2001-07       Impact factor: 5.115

4.  Diffuse leptomeningeal involvement by a ganglioglioma in a child. Case report.

Authors:  M R Wacker; P H Cogen; J E Etzell; L Daneshvar; R L Davis; M D Prados
Journal:  J Neurosurg       Date:  1992-08       Impact factor: 5.115

5.  Neuroblastomatous recurrence of ganglioglioma. Case report.

Authors:  K M David; S de Sanctis; P D Lewis; A M Noury; J M Edwards
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

Review 6.  Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: a study of 60 patients with intracranial tumors.

Authors:  R A Prayson; K Khajavi; Y G Comair
Journal:  J Neuropathol Exp Neurol       Date:  1995-07       Impact factor: 3.685

7.  Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report.

Authors:  A Sasaki; J Hirato; Y Nakazato; M Tamura; H Kadowaki
Journal:  J Neurosurg       Date:  1996-06       Impact factor: 5.115

8.  Anaplastic ganglioglioma in an infant: case report and review of the literature.

Authors:  W A Hall; E J Yunis; A L Albright
Journal:  Neurosurgery       Date:  1986-12       Impact factor: 4.654

9.  Central nervous system gangliogliomas. Part 1: Pathology.

Authors:  D C Miller; F F Lang; F J Epstein
Journal:  J Neurosurg       Date:  1993-12       Impact factor: 5.115

10.  Ganglioglioma: a correlative clinicopathological and radiological study of ten surgically treated cases with follow-up.

Authors:  U P Kalyan-Raman; W C Olivero
Journal:  Neurosurgery       Date:  1987-03       Impact factor: 4.654

View more
  4 in total

1.  Malignant and benign ganglioglioma: a pathological and molecular study.

Authors:  Ajay Pandita; Anandh Balasubramaniam; Richard Perrin; Patrick Shannon; Abhijit Guha
Journal:  Neuro Oncol       Date:  2007-01-26       Impact factor: 12.300

2.  Genetic Characterization of a Multifocal Ganglioglioma Originating Within the Spinal Cord.

Authors:  Joshua L Wang; Christopher S Hong; Jose Otero; Vinay K Puduvalli; J Bradley Elder
Journal:  World Neurosurg       Date:  2016-09-23       Impact factor: 2.104

3.  Heterogeneity and excitability of BRAFV600E-induced tumors is determined by Akt/mTOR-signaling state and Trp53-loss.

Authors:  Silvia Cases-Cunillera; Karen M J van Loo; Julika Pitsch; Anne Quatraccioni; Sugirthan Sivalingam; Paolo Salomoni; Valeri Borger; Dirk Dietrich; Susanne Schoch; Albert J Becker
Journal:  Neuro Oncol       Date:  2022-05-04       Impact factor: 13.029

4.  Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas.

Authors:  Samantha Mascelli; Annalisa Barla; Alessandro Raso; Sofia Mosci; Paolo Nozza; Roberto Biassoni; Giovanni Morana; Martin Huber; Cristian Mircean; Daniel Fasulo; Karin Noy; Gayle Wittemberg; Sara Pignatelli; Gianluca Piatelli; Armando Cama; Maria Luisa Garré; Valeria Capra; Alessandro Verri
Journal:  BMC Cancer       Date:  2013-08-15       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.